Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01300624 · ClinicalTrials.gov registry record · Phase 2
Effect of Verb Network Strengthening Treatment (VNeST) on Lexical Retrieval in Aphasia
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT01300624: Completed Phase 2 study, sponsored by US Department of Veterans Affairs.
NCT01300624 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 11 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01300624, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of Verb Network Strengthening Treatment (VNeST) on the ability to produce sentences and connected speech in persons with aphasia.
Primary Outcome
Picture description task that include trained words.
Interventions
- BEHAVIORAL Verb Network Strengthening Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
What the finished NCT01300624 record still lists
NCT01300624 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Verb Network Strengthening Treatment is the first listed.
NCT01300624 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01300624 about?
NCT01300624 is a clinical study titled "Effect of Verb Network Strengthening Treatment (VNeST) on Lexical Retrieval in Aphasia". The purpose of this study is to evaluate the effect of Verb Network Strengthening Treatment (VNeST) on the ability to produce sentences and connected speech in persons with aphasia.
What is the current status of trial NCT01300624?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2011-03. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01300624?
The interventions under investigation include: Verb Network Strengthening Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01300624?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01300624's enrollment target sits among peer trials
11 1967th of 2000 higher than 33 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia